The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).
Investigators will develop and pilot test a prototype of the MyMAP intervention.The intervention is designed to help smokers better manage issues known to reduce treatment adherence (withdrawal symptoms, medication side-effects, low motivation, and inadequate behavioral skills for medication adherence) and to facilitate greater communication between patients and providers so clinicians can provide appropriate oversight of medication use, intervene when medically necessary, and address patient concerns that may otherwise lead to non-adherence or early treatment termination.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
66
Standard 12 week course of varenicline, provided in both arms
Standard self-help education for smoking cessation, delivered via mobile-optimized website accessible via smartphone.
Same standard self-help intervention as in control arm + automatically-tailored support and advice for managing nicotine withdrawal symptoms + secure messaging with cessation counselor
Group Health Research Institute
Seattle, Washington, United States
Point Prevalence Abstinence
Self-report of no-smoking, even a puff during the last 7 days.
Time frame: 5 month follow-up
Number of Days of Varenicline Use
Number of days varenicline was used
Time frame: 5 mo follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.